Mumbai, Nov. 6 -- Symbiotec Pharmalab, a science-driven pharmaceutical and biotechnology company, today announced a 10-year, take-or-pay contract development and manufacturing agreement with a European alternative protein innovator. The agreement reserves dedicated capacity for the partner at Symbiotec's Ujjain campus for the full term.

Published by HT Digital Content Services with permission from Capital Market....